HOME >> MEDICINE >> NEWS
JCI table of contents: January 19, 2006

of the fibronectin scaffold by pro-angiogenic astrocytes.

TITLE: Tlx acts as a pro-angiogenic switch by regulating extracellular assembly of fibronectin matrices in retinal astrocytes

AUTHOR CONTACT:
Akiyoshi Uemura
RIKEN Center for Developmental Biology, Kobe, Japan
Phone: 81-78-306-1924; Fax: 81-78-306-1895; E-mail: auemura@cdb.riken.jp

View the PDF of this article at: https://www.the-jci.org/article.php?id=25964

IMMUNOLOGY
TLR2 both triggers and tames the immune response

It is an established premise that invading pathogens release antigens that bind to Toll-like receptors (TLR ligands) on the surface of various cells of the immune system. This event stimulates specialized immune cells to release secreted proteins that activate other immune cells, such as T cells, to join the fight to destroy invading bacteria or fungi. The proliferation and activity of T cells is carefully controlled by a subset of cells known as regulatory T cells (Tregs). Treg depletion may allow an overzealous immune response to turn against the body's own tissues, resulting in autoimmune disorders such as arthritis and diabetes, while overactive Tregs can hinder the immune response against a foreign pathogen. In a study in mice appearing online on January 19 in advance of print publication in the February 2006 issue of the Journal of Clinical Investigation, Gosse Adema and colleagues at the Radboud University Nijmegen Medical Centre in The Netherlands, reveal that the type 2 TLR (TLR2) lies at the center of how Tregs know when to suppress and when not to suppress the immune response. The authors show that during infection of mice with the fungus Candida albicans, TLR2 ligands bind directly to TLR2 on Tregs and promote Treg proliferation. Interestingly, this binding also temporarily inhibits the suppressive activ
'"/>

Contact: Brooke Grindlinger
press_releases@the-jci.org
212-342-9006
Journal of Clinical Investigation
19-Jan-2006


Page: 1 2 3 4 5 6

Related medicine news :

1. International symposium on fruit, vegetables headed for Houston
2. Stevens Roundtable: Health, Technology & Society, July 11
3. FDA approves ZYFLO CR extended-release tablets for chronic treatment of asthma
4. Once-fatal metabolic disorders treatable, says Stanford/Packard researcher
5. Clinical review -- A psychological approach to the management of irritable bowel syndrome
6. JCI table of contents -- May 17, 2007
7. JCI table of contents: May 10, 2007
8. New treatments needed for irritable bowel syndrome
9. JCI table of contents: May 1, 2007
10. Americans still not eating enough fruits and vegetables, according to 2 recent studies
11. Slow-release morphine reduces level of intractable cough

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: JCI table contents January

(Date:5/28/2015)... Hexagon Geospatial is pleased to announce that ... engineering, spatial data and mapping services, is using Hexagon ... clouds for urban change assessments in Bernalillo County, New ... Spatial Data Division implemented a countywide approach to generating ... by a variety of different digital aerial camera systems, ...
(Date:5/28/2015)... May 28, 2015 lifeIMAGE ... round of financing led by Cambia Health Solutions ... dedicated to transforming health care by creating a person-focused ... most utilized network for exchanging medical imaging, will use ... base, increase the breadth of its network capabilities and ...
(Date:5/28/2015)... 28, 2015 WebWatcher, the ... their partnership with BeSure Consulting to help ... The partnership will combine BeSure Consulting’s ... parental monitoring software solution. , Led by ... Consulting's passion is concentrated on teaching law ...
(Date:5/28/2015)... PA (PRWEB) May 28, 2015 A ... and adventures. Each item on the bucket ... impossible events, experiences and tasks that the owner wants ... no right or wrong when it comes to making ... a business, writing poems, publishing a book, seeing the ...
(Date:5/28/2015)... Ask not what your racquet can do for you ... your racquet. With the launch of their new digital campaign, ... astonishing tricks and unique skill to HEAD Pro Players and ... trick artist playfully demonstrates how to gain more control over ... but also challenges tennis enthusiasts everywhere to join the show. ...
Breaking Medicine News(10 mins):Health News:Hexagon Geospatial Supports Urban Change Detection Programs in New Mexico 2Health News:Hexagon Geospatial Supports Urban Change Detection Programs in New Mexico 3Health News:Cambia Health Solutions Leads New Round of Investment in lifeIMAGE 2Health News:Cambia Health Solutions Leads New Round of Investment in lifeIMAGE 3Health News:Cambia Health Solutions Leads New Round of Investment in lifeIMAGE 4Health News:WebWatcher Partners with BeSure Consulting 2Health News:WebWatcher Partners with BeSure Consulting 3Health News:Tennis Artist Baffles Novak Djokovic - HEAD Launches Trick Shot Campaign “Frame & Play” 2
(Date:5/28/2015)...  Pharmaceutic Labs announces its official status as ... the FDA,s Drug Quality and Security Act. To ... to Current Good Manufacturing Practice (CGMP) and increased ... highest standards of CGMP 21 CFR Part 210 ... with FDA regulations and ensure patient safety, Pharmaceutic ...
(Date:5/28/2015)... INDIANAPOLIS , May 28, 2015  Eli ... final results of the Phase III PROCLAIM trial ... presentation at the American Society of Clinical Oncology ... . PROCLAIM was a randomized, Phase III superiority ... lung cancer (NSCLC), which evaluated Lilly,s ALIMTA ® ...
(Date:5/28/2015)... Research and Markets( http://www.researchandmarkets.com/research/rjpc7h/2015_strategies ) has ... in the US Ancillary Hospital Locations (ERs, ORs, ... offering. This new 973-page report contains ... diagnostic testing markets outside the main hospital laboratory ... of the market dynamics, size, growth, regulatory requirements, ...
Breaking Medicine Technology:PROCLAIM Final Trial Results to be Presented at ASCO Annual Meeting 2PROCLAIM Final Trial Results to be Presented at ASCO Annual Meeting 3PROCLAIM Final Trial Results to be Presented at ASCO Annual Meeting 4PROCLAIM Final Trial Results to be Presented at ASCO Annual Meeting 5PROCLAIM Final Trial Results to be Presented at ASCO Annual Meeting 6PROCLAIM Final Trial Results to be Presented at ASCO Annual Meeting 7PROCLAIM Final Trial Results to be Presented at ASCO Annual Meeting 8Strategies in the US Ancillary Hospital Locations (ERs, ORs, ICUs) Diagnostic Testing Market 2015-2020 2
Cached News: